Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Enhancement of magenesium uptake in mammals

a technology of magnesium uptake and mammals, applied in the field of increasing magnesium uptake in mammals, can solve the problems of inability to absorb magnesium, high blood pressure, and a variety of serious physical and mental problems, and achieve the effect of enhancing magnesium uptak

Inactive Publication Date: 2011-07-28
JAFFE RUSSELL
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"This patent describes a new way to give magnesium to mammals, including humans. It involves giving them a magnesium salt, a special amino acid or phospholipid, and a special acid. This can be done orally. The special amino acid can be choline, and the special acid can be citrate. This method helps to increase the amount of magnesium that can be taken up by the mammal's body."

Problems solved by technology

Considering that magnesium is an activator for so many important body functions, it is not surprising that deficiency can lead to a variety of serious physical and mental problems.
In addition, nerve irritability, mood instability, high blood pressure (Essential, otherwise unexplained), angina (chest pain on exertion), heart arrythmias (magnesium is ‘nature's calcium channel blocker’) calcium loss / osteoporosis risk and insomnia are also associated with magnesium deficiency.
However, there are many factors that can inhibit the body's ability to absorb magnesium.
Oral intakes of magnesium are difficult for the body to absorb.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enhancement of magenesium uptake in mammals

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0023]A 26 year old man suffering from supraventricular arrythmias was unresponsive to medication and, despite detailed medical workup, was determined to be ‘idiopathic’.

[0024]Clinical assessments were done over periods of one month. Magnesium salts were administered to the subject for one month followed by one month of choline citrate alone followed by one month of magnesium salts along with concurrent administration of choline citrate.

[0025]During this time the patient was instructed to count the number of irregular heart beats (IHB) over a 2 minute period on rising and before bed. The average number of irregular heart beat counted over the three month time period can be found in table 1:

TABLE 1AMPMTotalMonth 1 (ave)132235Month 2 (ave)112738Month 3 (ave)134

[0026]As shown in table 1, the average number of irregular heart beats decreased drastically when the magnesium salts were administered along with concurrent administration of choline citrate.

example 2

[0027]A 72 year old woman suffering from ectopic heart beats which were unresponsive to medication and, despite detailed medical workup, was determined to be ‘idiopathic’.

[0028]Clinical assessments were done over periods of one month. Magnesium salts were administered to the subject for one month followed by one month of choline citrate alone followed by one month of magnesium salts along with concurrent administration of choline citrate.

[0029]During this time the patient was instructed to count the number of irregular heart beats (IHB) over a 2 minute period on rising and before bed. The average number of irregular heart beat counted over the three month time period can be found in table 2:

TABLE 2AMPMTotalMonth 1 (ave)182038Month 2 (ave)221941Month 3 (ave)123

[0030]As shown in table 2, the average number of irregular heart beats decreased drastically when the magnesium salts were administered along with concurrent administration of choline citrate.

example 3

[0031]A 59 year old man suffered from ‘restless legs’ and intermittent leg cramps during sleep. Clinical assessments were done with the subject taking magnesium salts for weeks 1 and 2, followed with the subject taking choline citrate alone for weeks 3 and 4, followed with the subject taking magnesium salts along with concurrent administration of choline citrate in weeks 5-9.

[0032]Each week the subject was asked to rate the intensity of the problem on a consistent rating scale with ‘0’ indicating no problem and ‘100’ indicating the most severe expression of the condition. The results can be found in table 3.

TABLE 3Ave. intensity of legcramp related difficultyWeek 1-288Week 3-483Week 563Week 644Week 729Week 812Week 97

[0033]As shown in table 3, the average intensity of the leg cramp related difficulty decreased drastically when the magnesium salts were administered along with concurrent administration of choline citrate.

[0034]The clinical assessments shown in Examples 1-3, are consist...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
electrical potentialsaaaaaaaaaa
blood pressureaaaaaaaaaa
Login to View More

Abstract

Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts with one or more quaternary amines and / or phosphatides and one or more di- or tri-carboxylic acids.

Description

FIELD OF INVENTION[0001]The present invention relates to increasing magnesium uptake in mammals. More particularly, the present inventions relates to increasing magnesium uptake in mammals by concurrently administering one or more magnesium salts, with one or more quaternary amines or phosphatides and one or more di- or tri-carboxylic acids.BACKGROUND OF THE INVENTION[0002]Magnesium is an important mineral in mammalian nutrition. As part of adenosine triphosphate (ATP), magnesium is used for all biosynthetic processes, glycolysis, formation of cyclic adenosine monophosphate (cyclic AMP), is involved in energy metabolism and energy dependent membrane transport and is used for ribonucleic acid (RNA) synthesis and transmission of the genetic code.[0003]Magnesium, as a cation, is involved in over 10,000 enzyme (cell catalyst) actions. Magnesium is especially important to enzymes concerned with oxidative phosphorylation. Magnesium is also an important component of both intracellular and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A23L1/304A61K31/13A61K31/19A61K31/685A61K33/06
CPCA61K31/13A61K31/19A61K31/685A61K33/06A61K2300/00A61P3/02A61P9/06
Inventor JAFFE, RUSSELL
Owner JAFFE RUSSELL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com